Can we talk about pharmaceutical sovereignty in Canada if Canada funds discovery, but doesn't sufficiently support development through to clinical trials and to the patient, in particular?
Maxime Blanchette-Joncas Bloc Rimouski—La Matapédia, QC
Can we talk about pharmaceutical sovereignty in Canada if Canada funds discovery, but doesn't sufficiently support development through to clinical trials and to the patient, in particular?
See context to find out what was said next.